DYRK1A BAC Transgenic Mouse: A New Model of Thyroid Dysgenesis in Down Syndrome
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The most common thyroid abnormality among Down syndrome (DS) children corresponds to a mildly elevated TSH, with T4 decreased or in the normal range and thyroid hypoplasia, from the neonatal period onward, which aggravate their mental impairment. Transgenic Dyrk1A mice, obtained by bacterial artificial chromosome engineering (mBACTgDyrk1A), have 3 copies of the Dyrk1A gene. The objective is to determine whether this transgenic Dyrk1A (Dyrk1A+/++) mouse is an adequate murine model for the study of thyroid dysgenesis in DS. Embryonic thyroid development from embryonic day 13.5 (E13.5) to E17.5 was analyzed in wild-type (WT) and Dyrk1A+/++ mice by immunofluorescence with anti-Nkx2–1, anti-thyroglobulin, and anti-T4 antibodies, markers of early thyroid development, hormonogenesis, and final differentiation, respectively. The expression of transcription factors Nkx2–1, Pax8, and Foxe1 involved in thyroidogenesis were studied by quantitative RT-PCR at the same embryonic stages. We then compared the adult phenotype at 8 to 12 weeks in Dyrk1A+/++ and WT mice for T4 and TSH levels, thyroidal weight, and histological analysis. Regarding thyroidal development, at E15.5, Dyrk1A+/++ thyroid lobes are double the size of WT thyroids (P = .01), but the thyroglobulin stained surface in Dyrk1A+/++ thyroids is less than a third as large at E17.5 (P = .04) and their differentiated follicular surface half the size (P = .004). We also observed a significant increase in Nkx2–1, Foxe1, and Pax8 RNA levels in E13.5 and E17.5 Dyrk1A+/++ embryonic thyroids. Dyrk1A+/++ young adult mice have significantly lower plasma T4 (2.4 ng/mL versus WT, 3.7 ng/mL; P = 0.019) and nonsignificantly higher plasma TSH (114 mUI/L versus WT, 73mUI/L; P = .09). In addition, their thyroids are significantly heavier (P = .04) and exhibit large disorganized regions. Dyrk1A overexpression directly leads to thyroidal embryogenetic, functional and morphological impairment. The young adult thyroid phenotype is probably a result of embryogenetic impairment. The Dyrk1A+/++ mouse can be considered a suitable study model for thyroid dysgenesis in DS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The probable cause of both phenomena is TD, probably related to the extra chromosome 21 and possibly to overexpression of the DYRK1A gene (40–43).”
In the citing paper
“With respect to the cause of the mild nonautoimmune subclinical hypothyroidism in neonates and infants with Down's syndrome, new insights were provided by a study in Dyrk1A (+/++) mice, showing abnormal thyroid development and function (42).”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Singh, B. N., Shankar, S., & Srivastava, R. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.093 · Cited by 1,602
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Arron, J. R., Winslow, M. M., Polleri, A., Chang, C.-P., Wu, H., Gao, X., Neilson, J. R., Chen, L., Heit, J. J., Kim, S. K., et al. (2006) · Nature · doi:10.1038/nature04678 · Cited by 698
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
Self-citationAltafaj, X. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.18.1915 · Cited by 396
De la Torre, R., De Sola, S., Pons, M., Duchon, A., de Lagran, M. M., Farré, M., Fitó, M., Benejam, B., Langohr, K., Rodriguez, J., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300325 · Cited by 286
Self-citationThyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity
Karlsson, B., Gustafsson, J., Hedov, G., Ivarsson, S.-A., & Anneren, G. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.79.3.242 · Cited by 279
DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects
Ahn, K.-J., Jeong, H. K., Choi, H.-S., Ryoo, S.-R., Kim, Y. J., Goo, J.-S., Choi, S.-Y., Han, J.-S., Ha, I., & Song, W.-J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.006 · Cited by 220
Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
Guedj, F., Sébrié, C., Rivals, I., Ledru, A., Paly, E., Bizot, J. C., Smith, D., Rubin, E., Gillet, B., Arbones, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004606 · Cited by 216
Self-citationAbnormalities of thyroid function in infants with Down syndrome
Fort, P., Lifshitz, F., Bellisario, R., Davis, J., Lanes, R., Pugliese, M., Richman, R., Post, E. M., & David, R. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80544-2 · Cited by 212
Research works printed but not linked: 1
- Roberts, 1997, Population study of congenital hypothyroidism and associated birth defects, Atlanta, 1979–1992, Am J Med Genet, 71, 29, 10.1002/(SICI)1096-8628(19970711)71:1<29::AID-AJMG5>3.0.CO;2-L · doi:10.1002/(sici)1096-8628(19970711)71:1<29::aid-ajmg5>3.0.co;2-l
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“With respect to the cause of the mild nonautoimmune subclinical hypothyroidism in neonates and infants with Down’s syndrome, new insights were provided by a study in Dyrk1A (+/++) mice, showing abnormal thyroid development and function (42).”
BackgroundSelf-citationDevelopment of the thyroid gland
Nilsson, M., & Fagman, H. (2017) · Development · doi:10.1242/dev.145615 · Cited by 286
“The need for tight control of thyroid cell proliferation is emphasized by recent observations in a mouse model of Down syndrome in which overexpression of Dyrk1a, the candidate gene for the trisomy 21 phenotype, leads to fetal thyroid hyperplasia and increased final thyroid size (Kariyawasam et al., 2015).”
BackgroundInfluentialDierssen, M., Fructuoso, M., Martínez de Lagrán, M., Perluigi, M., & Barone, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00670 · Cited by 101
TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology
Stoupa, A., Adam, F., Kariyawasam, D., Strassel, C., Gawade, S., Szinnai, G., Kauskot, A., Lasne, D., Janke, C., Natarajan, K., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809569 · Cited by 71
“The sections were then analysed using ImageJ 1.32s (freeware, www.rsbweb.nih.gov/ij) as previously described (Carre et al, 2011; Kariyawasam et al, 2015).”
MethodSelf-citationNew genetics in congenital hypothyroidism
Stoupa, A., Kariyawasam, D., Muzza, M., de Filippis, T., Fugazzola, L., Polak, M., Persani, L., & Carré, A. (2021) · Endocrine · doi:10.1007/s12020-021-02646-9 · Cited by 59
“New insights were provided by a study in Dyrk1A(+/++) mice showing abnormal thyroid development and function [12].”
BackgroundSelf-citationGenetics of congenital hypothyroidism: Modern concepts
Stoupa, A., Kariyawasam, D., Polak, M., & Carré, A. (2022) · Pediatric Investigation · doi:10.1002/ped4.12324 · Cited by 58
Self-citationDisorders of thyroid morphogenesis
Abu-Khudir, R., Larrivée-Vanier, S., Wasserman, J. D., & Deladoëy, J. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.04.008 · Cited by 46
Early thyroxine treatment in Down syndrome and thyroid function later in life
Zwaveling-Soonawala, N., Witteveen, M. E., Marchal, J. P., Klouwer, F. C. C., Ikelaar, N. A., Smets, A. M. J. B., van Rijn, R. R., Endert, E., Fliers, E., & van Trotsenburg, A. S. P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0858 · Cited by 23
Stoupa, A., Carré, A., Polak, M., Szinnai, G., & Schoenmakers, N. A. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0348 · Cited by 30
“5 embryonic thyroids, premature overexpression of Nkx2 – 1 , Foxe1 and Pax8 transcripts are noted (135).”
Self-citationStructure-activity relationship for the folding intermediate-selective inhibition of DYRK1A
Miyazaki, Y., Kikuchi, M., Umezawa, K., Descamps, A., Nakamura, D., Furuie, G., Sumida, T., Saito, K., Kimura, N., Niwa, T., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113948 · Cited by 14
Thyroid hormone and folinic acid in young children with Down syndrome: the phase 3 ACTHYF trial
Mircher, C., Sacco, S., Bouis, C., Gallard, J., Pichot, A., Galloudec, E. L., Cieuta‐Walti, C., Marey, I., Greiner-Mahler, O., Dorison, N., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0597-8 · Cited by 13
Self-citationMolinari, S., FOSSATI, C., Nicolosi, M. L., Marco, S. D., Faraguna, M. C., Limido, F., Ocello, L., Pellegrinelli, C., Lattuada, M., Gazzarri, A., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1348397 · Cited by 24
Shaping the thyroid: From peninsula to de novo lumen formation
Pierreux, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111313 · Cited by 12
van Trotsenburg, A. S. P., Stoupa, A., Léger, J., Rohrer, T. R., Peters, C. J., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.3.8 · Cited by 9
Self-citationThe Consensus on the Diagnosis and Management of Congenital Hypothyroidism in Term Neonates
Hashemipour, M., Rabbani, A., Rad, A. H., & Dalili, S. (2023) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_535_21 · Cited by 12
Cattoni, A., Molinari, S., Capitoli, G., Masera, N., Nicolosi, M. L., Barzaghi, S., Marziali, G., Lazzerotti, A., Gazzarri, A., Vimercati, C., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad333 · Cited by 8
Lauffer, P., Zwaveling‐Soonawala, N., Li, S., Bacalini, M. G., Naumova, O. Y., Wiemels, J. L., Boelen, A., Henneman, P., de Smith, A. J., & van Trotsenburg, A. S. P. (2022) · Thyroid · doi:10.1089/thy.2022.0320 · Cited by 6
“34 However, in humans, DYRK1A has not yet been associated with thyroid dysfunction.”
Embryonic organizer formation disorder leads to multiorgan dysplasia in Down syndrome
Liu, Y., Lin, Z., Peng, Y., Jiang, Y., Zhang, X., Zhu, H., Zhang, L., Chen, J., Shu, X., Luo, M., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05517-x · Cited by 6
“Therefore it can be considered the cause of the observed DS phenotype [16, 17].”
Borealin/CDCA8 deficiency alters thyroid development and results in papillary tumor-like structures
Didier-Mathon, H., Stoupa, A., Kariyawasam, D., Yde, S., Cochand‐Priollet, B., Groussin, L., Sebag, F. A., Cagnard, N., Nitschké, P., Luton, D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1286747 · Cited by 6
Self-citationDermitzaki, N., Serbis, A., Baltogianni, M. S., Gialamprinou, D., Giaprou, L. E., Kosmeri, C., & Giapros, V. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210849 · Cited by 7
“Studies on experimental animals have demonstrated that the DYRK1A gene, which is located in the critical region of chromosome 21 associated with Down syndrome, is probably implicated in cases of thyroid dysgenesis [24,127,128].”
Génétique de l’hypothyroïdie congénitale
Stoupa, A., Kariyawasam, D., Polak, M., & Carré, A. (2022) · médecine/sciences · doi:10.1051/medsci/2022028 · Cited by 7
Self-citationGorini, F., Coi, A., Pierini, A., Assanta, N., Bottoni, A., & Santoro, M. C. (2024) · Children · doi:10.3390/children11050513 · Cited by 10
“…considered as one of the main candidate regions to be responsible for most DS features, contains important candidate genes such as the dual-specificity tyrosine (Y)-phosphorylation regulated kinase 1 A (DYRK1A), the overexpression of which is believed to affect early thyroid morphogenesis [62,63].”
BackgroundKnowns and unknowns about congenital hypothyroidism: 2022 update
Itonaga, T., Hasegawa, Y., Higuchi, S., Satoh, M., Sawada, H., Shimura, K., Takahashi, I., Takubo, N., & Nagasaki, K. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0016 · Cited by 7
“2 deletion syndrome), JAG1 (Alagille syndrome) and KAT6B (Ohdo syndrome, Genitopatellar syndrome) (63–67).”
Thyroid Function in Children with Down Syndrome
Francis, G. L. (2023) · Clinical Thyroidology · doi:10.1089/ct.2023;35.355-359 · Cited by 1
“Alter-natively, overexpression of dual-specificity tyrosine phosphorylation-regulated kinase 1A ( Dyrk1a , also located on chromosome 21) could lead to thyroid hypoplasia and subclinical hypothyroidism (8).”
Stoupa, A., Carré, A., Polak, M., & Szinnai, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-812531-1.00013-0 · Cited by 1
Self-citationvan Trotsenburg, A. S. P., & Zwaveling‐Soonawala, N. (2022) · doi:10.1093/med/9780198870197.003.0174
Panorama das disfunções tireoidianas em crianças com Síndrome de Down
Prestes, A. C. R., Lopes, M. C. M., Diogo, L. R. F., Gonçalves, F. L., Begot, M. B. P., de Sousa, A. M., Hanna, L. M. O., & Acatauassú, S. T. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv8n4-264
de Souza, J. S., Sánchez-Sánchez, S. M., Amelinez-Robles, N., Guerra, B. S., Giannocco, G., & Muotri, A. R. (2025) · Cells · doi:10.3390/cells14181407 · Cited by 1
“For example, overexpression of Dyrk1a is related to thyroid development dysfunction [31].”
Congenital hypothyroidism in two children affected by Sotos syndrome: a simple association?
Cavarzere, P., Munari, S., Arrigoni, M., Raitano, V., Fiorini, E., Guzzo, A., Gaudino, R., & Antoniazzi, F. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-025-02114-4
“CH is also commonly present in syndromic conditions such as Down syndrome [23–25], DiGeorge syndrome [26], Williams syndrome [27], and the rarer Kabuki syndrome [20, 28].”
DYRK1A Expression and Thyroid Dysfunction in Subjects With Down Syndrome
Khatri, A., Dutta, S., Mukhopadhyay, A., Deshpande, A., Ghosh, S., Bhattacharyya, N. P., Mukhopadhyay, P., & Ghosh, S. K. (2026) · Clinical Endocrinology · doi:10.1111/cen.70099
“A recent study on a murine model suggested that over-expression of the Dyrk1A (triplicate) gene may lead to altered anatomical development of the thyroid and thyroid dysfunction [15].”
Metadata
- Authors
- Kariyawasam, D., Rachdi, L., Carré, A., Martin, M., Houlier, M., Janel, N., Delabar, J.-M., Scharfmann, R., & Polak, M.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Inserm (FR)
- Diabetes and Obesity Research Laboratory (M.M.), Institut d'Investigacions Biomèdiques August Pi I Sunyer, 08036 Barcelona, Spain
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Polak, Michel
- ORCID
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2015-03-01
- Volume
- 156
- Issue
- 3
- Pages
- 1171-1180
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2015639284
- Cited by
- 30
- References
- 39
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 3
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institute of Genetics
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- Down syndrome, DYRK1A, thyroid dysgenesis, thyroid hypoplasia, transgenic mouse model, bacterial artificial chromosome, thyroid development, thyroglobulin, TTF-1, PAX8, FOXE1, thyroxine, thyroid-stimulating hormone, intellectual disability
- MeSH terms
- Dyrk Kinases, Animals, Disease Models, Animal, Down Syndrome, Female, Humans, Mice, Transgenic, Protein-Tyrosine Kinases, Thyroid Gland, Protein Serine-Threonine Kinases, Gene Expression Regulation, Developmental, Chromosomes, Artificial, Bacterial, Thyroid Dysgenesis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.